<p><strong>Purpose.</strong> Assessment of predictors of cancer-specific survival (CSS) in patients at high risk of progression of muscle-invasive bladder cancer (MIBC) after radical cystectomy that have been included in a prospective, randomized study to assess efficacy of shortened course of adjuvant chemotherapy.</p><p><strong>Material and methods.</strong> A total of 92 patients were included in the study. Prognostic significance of age, gender, recurrent status of urinary diversion, pT category and pN, the number of distant lymph nodes (LN), the degree of differentiation and the presence of metaplasia, the number of metastatic lesions of the LN and LN-density lesion on CSS were evaluated with Cox proportional hazard model.</p><p><stron...
Abstract Background Identifying the likelihood of life‐threatening recurrence after radical cystecto...
AimTo determine the difference in survival after cystectomy between patients presenting with primary...
Prognostic factors for survival after recurrent MIBC are unknown and were evaluated using a populati...
Objectives To identify clinicopathological factors that predict outcomes in patients with a single...
To better understand the result of radical cystectomy in the treatment of bladder cancer, we analyze...
Objective To externally validate the pT4a-specific risk model for cancer-specific survival (CSS) pro...
BACKGROUND: Bladder cancer is the fourth most frequently diagnosed cancer among males and the eleve...
OBJECTIVE: To identify the clinical and pathological prognostic factors in a homogeneous series of ...
Background and objective: Patients with carcinoma urinary bladder with metastasis to the lymph nodes...
Bladder cancer is a major cause of morbidity and mortality. At initial diagnosis, 75% of patients pr...
Objective To stratify patients with bladder cancer into homogeneous risk groups according to statist...
Objectives: To examine the association between local recurrence and distant metastasis or disease-sp...
International audienceIntroduction: Adjuvant therapy has no defined role for patients with positive ...
Introduction: Adjuvant therapy has no defined role for patients with positive surgical margins (PSMs...
Background/PurposeTo better understand the result of radical cystectomy in the treatment of bladder ...
Abstract Background Identifying the likelihood of life‐threatening recurrence after radical cystecto...
AimTo determine the difference in survival after cystectomy between patients presenting with primary...
Prognostic factors for survival after recurrent MIBC are unknown and were evaluated using a populati...
Objectives To identify clinicopathological factors that predict outcomes in patients with a single...
To better understand the result of radical cystectomy in the treatment of bladder cancer, we analyze...
Objective To externally validate the pT4a-specific risk model for cancer-specific survival (CSS) pro...
BACKGROUND: Bladder cancer is the fourth most frequently diagnosed cancer among males and the eleve...
OBJECTIVE: To identify the clinical and pathological prognostic factors in a homogeneous series of ...
Background and objective: Patients with carcinoma urinary bladder with metastasis to the lymph nodes...
Bladder cancer is a major cause of morbidity and mortality. At initial diagnosis, 75% of patients pr...
Objective To stratify patients with bladder cancer into homogeneous risk groups according to statist...
Objectives: To examine the association between local recurrence and distant metastasis or disease-sp...
International audienceIntroduction: Adjuvant therapy has no defined role for patients with positive ...
Introduction: Adjuvant therapy has no defined role for patients with positive surgical margins (PSMs...
Background/PurposeTo better understand the result of radical cystectomy in the treatment of bladder ...
Abstract Background Identifying the likelihood of life‐threatening recurrence after radical cystecto...
AimTo determine the difference in survival after cystectomy between patients presenting with primary...
Prognostic factors for survival after recurrent MIBC are unknown and were evaluated using a populati...